EarningsQ3 2024 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q3 2024 Earnings Report

0 Followers

MX:JAZZN Q3 2024 EPS Results

Actual EPS$120.05

Consensus EPS$99.86

Beat/MissBeat by +$20.20

One Year Ago EPS$87.91

Actual Revenue$19.16B

Expected Revenue$18.83B

Beat/MissBeat by +$334.51M

YoY Revenue Growth+8.52%

QuarterQ3 2024

Date11/06/2024

TimeAfter Close

Conference CallWednesday, November 6, 2024

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	116.93 / -	147.66	―
Aug 03, 2026	2026 (Q2)	112.15 / 103.71	-149.839	169.21% (+253.55)
May 05, 2026	2026 (Q1)	84.29 / 115.15	30.513	277.38% (+84.64)
Feb 24, 2026	2025 (Q4)	118.38 / 120.60	119.871	0.61% (+0.73)
Nov 05, 2025	2025 (Q3)	107.99 / 147.66	120.053	23.00% (+27.61)
Aug 05, 2025	2025 (Q2)	-138.14 / -149.84	96.26	-255.66% (-246.10)
May 06, 2025	2025 (Q1)	84.60 / 30.51	48.675	-37.31% (-18.16)
Feb 25, 2025	2024 (Q4)	106.47 / 119.87	91.175	31.47% (+28.70)
Nov 06, 2024	2024 (Q3)	99.86 / 120.05	87.906	36.57% (+32.15)
Jul 31, 2024	2024 (Q2)	89.40 / 96.26	81.912	17.52% (+14.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed